- Home
- WAFD vs HRMY Comparison
WAFD vs HRMY Comparison
Compare WAFD & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAFD | HRMY |
|---|---|---|
| Founded | 1917 | 2017 |
| Country | United States | United States |
| Employees | N/A | 293 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WAFD | HRMY |
|---|---|---|
| Price | $30.85 | $40.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $35.00 | ★ $44.11 |
| AVG Volume (30 Days) | ★ 1.3M | 866.4K |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | 5.20 | ★ 7.97 |
| EPS | ★ 2.45 | 1.84 |
| Revenue | $29,650,000.00 | ★ $868,453,000.00 |
| Revenue This Year | N/A | $19.75 |
| Revenue Next Year | $4.15 | $12.88 |
| P/E Ratio | ★ $12.79 | $22.46 |
| Revenue Growth | 7.79 | ★ 21.51 |
| 52 Week Low | $26.31 | $25.52 |
| 52 Week High | $39.49 | $43.49 |
Technical Indicators
Market Signals| Indicator | WAFD | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 23.21 | 44.35 |
| Support Level | $29.68 | $37.30 |
| Resistance Level | $33.78 | $43.38 |
| Average True Range (ATR) | 0.71 | 1.21 |
| MACD | -0.18 | -0.35 |
| Stochastic Oscillator | 11.51 | 2.11 |
Price Performance
Historical ComparisonAbout WAFD WaFd Inc.
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.